Natural Capsules Limited (NATCAPSUQ.BO)
INR 217.95
(2.81%)
INR 217.95
(2.81%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.55 Billion INR | -9.84% |
| 2022 | 1.72 Billion INR | 27.62% |
| 2021 | 1.35 Billion INR | 69.86% |
| 2020 | 795.13 Million INR | 29.18% |
| 2019 | 615.54 Million INR | 2.97% |
| 2018 | 597.8 Million INR | 9.18% |
| 2017 | 547.55 Million INR | 2.07% |
| 2016 | 536.42 Million INR | -13.55% |
| 2015 | 620.53 Million INR | -7.82% |
| 2014 | 673.2 Million INR | 15.02% |
| 2013 | 585.29 Million INR | 9.46% |
| 2012 | 534.72 Million INR | 22.19% |
| 2011 | 437.61 Million INR | 28.19% |
| 2010 | 341.38 Million INR | 17.7% |
| 2009 | 290.04 Million INR | 11.42% |
| 2008 | 260.31 Million INR | 28.94% |
| 2007 | 201.89 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 391.8 Million INR | -2.59% |
| 2023 FY | 1.55 Billion INR | -9.84% |
| 2023 Q1 | 377 Million INR | 0.2% |
| 2023 Q4 | 402.2 Million INR | 0.6% |
| 2023 Q3 | 399.8 Million INR | 6.56% |
| 2023 Q2 | 375.2 Million INR | -0.48% |
| 2022 FY | 1.72 Billion INR | 27.62% |
| 2022 Q2 | 450.6 Million INR | 1.97% |
| 2022 Q3 | 455 Million INR | 0.98% |
| 2022 Q1 | 441.9 Million INR | 6.37% |
| 2022 Q4 | 376.24 Million INR | -17.31% |
| 2021 Q1 | 257.1 Million INR | 11.23% |
| 2021 Q2 | 302 Million INR | 17.46% |
| 2021 Q3 | 376.1 Million INR | 24.54% |
| 2021 FY | 1.35 Billion INR | 69.86% |
| 2021 Q4 | 415.45 Million INR | 10.46% |
| 2020 Q2 | 186.6 Million INR | 16.63% |
| 2020 FY | 795.13 Million INR | 29.18% |
| 2020 Q4 | 231.13 Million INR | 6.27% |
| 2020 Q3 | 217.5 Million INR | 16.56% |
| 2020 Q1 | 160 Million INR | 2.27% |
| 2019 FY | 615.54 Million INR | 2.97% |
| 2019 Q4 | 156.44 Million INR | -4.43% |
| 2019 Q3 | 163.7 Million INR | 5.48% |
| 2019 Q1 | 140.2 Million INR | -11.44% |
| 2019 Q2 | 155.2 Million INR | 10.7% |
| 2018 Q3 | 153.3 Million INR | 6.75% |
| 2018 Q2 | 143.6 Million INR | 0.7% |
| 2018 Q1 | 142.6 Million INR | -8.92% |
| 2018 FY | 597.8 Million INR | 9.18% |
| 2018 Q4 | 158.3 Million INR | 3.26% |
| 2017 Q4 | 156.56 Million INR | 10.18% |
| 2017 Q2 | 174.44 Million INR | 56.02% |
| 2017 FY | 547.55 Million INR | 2.07% |
| 2017 Q1 | 111.81 Million INR | -20.57% |
| 2017 Q3 | 142.1 Million INR | -18.54% |
| 2016 Q2 | 126.02 Million INR | -3.42% |
| 2016 FY | 536.42 Million INR | -13.55% |
| 2016 Q1 | 130.49 Million INR | -10.83% |
| 2016 Q4 | 140.76 Million INR | -4.09% |
| 2016 Q3 | 146.76 Million INR | 16.46% |
| 2015 Q2 | 159.07 Million INR | 1.72% |
| 2015 Q3 | 145.18 Million INR | -8.73% |
| 2015 Q4 | 146.34 Million INR | 0.8% |
| 2015 FY | 620.53 Million INR | -7.82% |
| 2015 Q1 | 156.38 Million INR | -6.14% |
| 2014 Q2 | 166.85 Million INR | 2.06% |
| 2014 Q4 | 166.61 Million INR | -2.45% |
| 2014 FY | 673.2 Million INR | 15.02% |
| 2014 Q1 | 163.47 Million INR | 0.46% |
| 2014 Q3 | 170.8 Million INR | 2.37% |
| 2013 Q2 | 141.59 Million INR | 3.91% |
| 2013 Q3 | 144.69 Million INR | 2.19% |
| 2013 FY | 585.29 Million INR | 9.46% |
| 2013 Q4 | 162.73 Million INR | 12.47% |
| 2013 Q1 | 136.27 Million INR | 0.42% |
| 2012 Q4 | 135.7 Million INR | -4.89% |
| 2012 Q3 | 142.67 Million INR | 4.27% |
| 2012 Q2 | 136.82 Million INR | 14.47% |
| 2012 Q1 | 119.52 Million INR | -0.16% |
| 2012 FY | 534.72 Million INR | 22.19% |
| 2011 Q3 | 111.82 Million INR | 0.0% |
| 2011 FY | 437.61 Million INR | 28.19% |
| 2011 Q4 | 119.72 Million INR | 7.06% |
| 2010 FY | 341.38 Million INR | 17.7% |
| 2010 Q4 | 94.34 Million INR | 0.0% |
| 2009 Q4 | 74.08 Million INR | 0.0% |
| 2009 FY | 290.04 Million INR | 11.42% |
| 2008 FY | 260.31 Million INR | 28.94% |
| 2008 Q4 | 64.55 Million INR | 0.0% |
| 2007 Q4 | 55.32 Million INR | 0.0% |
| 2007 FY | 201.89 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 362.75 Million INR | -328.446% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 8.481% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -923.335% |
| MedPlus Health Services Limited | 56.24 Billion INR | 97.237% |
| ANG Lifesciences India Limited | 1.46 Billion INR | -6.372% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 23.092% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | -81.077% |
| Beryl Drugs Limited | 271.24 Million INR | -472.983% |
| Cian Healthcare Limited | 616.95 Million INR | -151.915% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -8355.01% |
| Concord Drugs Limited | 449.24 Million INR | -245.958% |
| Deccan Health Care Limited | 597.28 Million INR | -160.209% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -223.962% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -14716.672% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | -9.477% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -48.193% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 49.403% |
| Makers Laboratories Limited | 1.03 Billion INR | -49.783% |
| Medi-Caps Limited | 265.63 Million INR | -485.089% |
| Panchsheel Organics Limited | 1.05 Billion INR | -47.711% |
| Parmax Pharma Limited | 154.24 Million INR | -907.628% |
| Parnax Lab Limited | 1.88 Billion INR | 17.641% |
| Patidar Buildcon Limited | 2.3 Million INR | -67239.688% |
| Phaarmasia Limited | 305.93 Million INR | -408.02% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -23.928% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -189.492% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -138916.1% |
| Smruthi Organics Limited | 1.27 Billion INR | -21.761% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -469.371% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 66.471% |
| Trident Lifeline Limited | 446.28 Million INR | -248.252% |
| Transchem Limited | 4.09 Million INR | -37807.326% |
| Trinity League India Limited | 2.95 Million INR | -52584.746% |
| Tyche Industries Limited | 696.83 Million INR | -123.036% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -1410.721% |
| Vivanza Biosciences Limited | 278.89 Million INR | -457.277% |
| PRAVEG LIMITED | 915.96 Million INR | -69.679% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 88.539% |
| Sunil Healthcare Limited | 901.91 Million INR | -72.321% |
| Syschem (India) Limited | 2.33 Billion INR | 33.448% |
| Zenith Healthcare Limited | 144.71 Million INR | -973.958% |
| Zenlabs Ethica Limited | 585.63 Million INR | -165.389% |
| Mercury Laboratories Limited | 755.59 Million INR | -105.694% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -288.328% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -319.845% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -248.404% |
| Roopa Industries Limited | 715.53 Million INR | -117.207% |
| PANJON LTD. | 125.52 Million INR | -1138.199% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -928.447% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 75.979% |
| Crestchem Limited | 212.56 Million INR | -631.175% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -27893.516% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -131.002% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 55.359% |
| Trimurthi Limited | 42.23 Million INR | -3579.625% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -108.414% |
| Norris Medicines Limited | 56.35 Million INR | -2657.819% |
| Veerhealth Care Limited | 142.13 Million INR | -993.475% |
| Lactose (India) Limited | 1.13 Billion INR | -36.465% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -292.058% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 10.847% |
| Gennex Laboratories Limited | 867.14 Million INR | -79.232% |
| Denis Chem Lab Limited | 1.67 Billion INR | 7.39% |
| Colinz Laboratories Limited | 70.29 Million INR | -2110.937% |
| Godavari Drugs Limited | 1.56 Billion INR | 0.824% |
| Zenotech Laboratories Limited | 368.08 Million INR | -322.235% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -23.452% |
| Bharat Parenterals Limited | 2.59 Billion INR | 40.087% |
| Coral Laboratories Limited | 836.6 Million INR | -85.775% |
| Evoq Remedies Limited | 63.09 Million INR | -2363.465% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -51.872% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Auro Laboratories Limited | 526.99 Million INR | -194.917% |